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Background: Dizziness is one of the most challenging symptoms in medicine. No medication for dizziness in current use
has well-established curative or prophylactic value or is suitable for long-term palliative use. Unconventional remedies,
such as acupuncture, should be considered and scientifically evaluated. However, there has been relatively little evidence
in randomized controlled clinical trials on acupuncture to treat chronic dizziness. The aim of our study is to evaluate the
efficacy and safety of acupuncture in patients with dizziness.
Methods/Design: This trial is a randomized, single-blind, controlled study. A total of 80 participants will be randomly
assigned to two treatment groups receiving acupuncture and sham acupuncture treatment, respectively, for 4 weeks. The
primary outcome measures are the Dizziness Handicap Inventory (DHI) and the Vertigo Symptom Scale (VSS). Treatment
will be conducted over a period of 4 weeks, at a frequency of two sessions per week. The assessment is at baseline
(before treatment initiation), 4 weeks after the first acupuncture session, and 8 weeks after the first acupuncture session.
Discussion: The results from this study will provide clinical evidence on the efficacy and safety of acupuncture in patients
with chronic dizziness.
Trial registration: International Standard Randomized Controlled Trial Number Register: ISRCTN52695239
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Dizziness is one of the most challenging symptoms in
medicine, and the prevalence has been reported to be
between 11.1% and 28.9% [1]. It is associated with func-
tional disability, and 10 to 20% of sufferers fall because
of their symptoms [2]. Although spontaneous remission
is possible, many patients experience delays in vestibular
compensation, which lead to chronic symptoms that inter-
fere with everyday functional tasks [3]. Over 66% of dizzy
patients also experience psychological distress, often re-
sulting in a vicious cycle of fear, avoidance of symptom-
provoking movements, and increased handicap, retarding
recovery even further [4,5].
Dizziness can be produced by peripheral vestibular dis-
orders, central nervous system disorders, or combined* Correspondence: lcz623780@126.com
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reproduction in any medium, provided the orlesions, as well as other conditions [2]. Treatment typically
consists of reassurance and antivertiginous and antiemetic
drugs to relieve symptoms [6-9]. However, several reviews
of the management of dizziness have concluded that no
medication in current use has well-established curative or
prophylactic value or is suitable for long-term palliative
use [10]. Unconventional remedies, such as acupuncture,
should be considered and scientifically evaluated [11].
Acupuncture, which is one of the main treatment moda-
lities of traditional Chinese medicine, has been used for
both the prevention and treatment of chronic dizziness
for over three thousand years. The rapid development of
acupuncture both within and outside China over the last
few decades has itself led to great innovations in practice.
Many studies, including clinical reports and systematic
reviews, have investigated the benefits and success of
acupuncture in relieving symptoms for various chronic
diseases [12]. However, there has been relatively little. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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puncture to treat chronic dizziness.
The aim of our study is to evaluate the efficacy and
safety of acupuncture in patients with dizziness.
Methods/Design
This is a randomized, controlled prospective study. We will
perform the study according to common guidelines for
clinical trials (Declaration of Helsinki, International
Conference on Harmonisationand WHO Good Clinical
Practice standards, including certification by an external
audit). The trial protocol has been approved by the
Research Ethical Committee of Beijing Hospital of
Traditional Chinese Medicine Affiliated to Capital Medical
University (ref: 201316). This trial was registered with
ISRCTN at Current Controlled Trials (ISRCTN52695239).
Population
Patients will be recruited in the acupuncture clinic at
Beijing Hospital of Traditional Chinese Medicine, affili-
ated to Capital Medical University, with a target sample
size of 100 subjects. Our trial will be promoted by a poster
at this hospital. All candidates will go through a standard-
ized interview process and receive more information
about the study and the treatments. Patients will be in-
formed in a manner suggesting that two different types of
acupuncture treatment will be compared. One type will be
traditional acupuncture and the other will be a new typeObtain 100 par
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Figure 1 Study sequence.of acupuncture, and the efficacy of both types is uncertain.
Terms such as ‘placebo’ or ‘sham’ will not be mentioned.
The participants’ written consents will be obtained. The
purpose and procedures, and potential risks and benefits
of the study will also be explained thoroughly to the
participants. Participants will be able to withdraw from
the study at any time without consequence. The trial will
be executed from February 2013 to December 2015. All
recruit procedures will be recorded in a log file (Figure 1).
Inclusion criteria
Participants meeting the following criteria will be included:
1. Vertigo of unknown cause;
2. Dizziness of unknown cause;
3. Ménière’s disease;
4. Psychogenic dizziness;
5. Age 18 to 75 years, either sex.
Exclusion criteria
Participants meeting one or more of the following criteria
will be excluded:
1. Labyrinthitis;
2. Benign positional vertigo;
3. Vestibular neuronitis;
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Table 1 Acupoints and needling procedure for real acupoint in this trial
Acupoints Meridian Puncturing angle Depth (cun) Manipulation Twisting angle (degrees) Frequency (per minutes)
Baihui (GV20) Du meridian Transversely (unilateral) 0.5 to 0.8 Twirling, reinforcing, manipulation <90 120
Yintang (EX-HN3) Extra nervepoint Transversely (unilateral) 0.3 to 0.5 Moderatereinforcing, reducing,
twisting, manipulation
90 to 180 60 to 120
Taiyang (EX-HN5) Extra nervepoint Perpendicularly (bilateral) 0.3 to 0.5 Moderatereinforcing, reducing,
twisting, manipulation
90 to 180 60 to 120
Tinggong (SI19) Small intestine, meridian Perpendicularly (bilateral) 1 to 1.5 Twirling, reinforcing, manipulation <90 >120
Wangu (GB12) Gallbladdermeridian Transversely (bilateral) 0.5 to 0.8 Twirlingreinforcing, manipulation <90 >120
Fengchi (GB20) Gallbladdermeridian Obliquelydownwardto
the nose (bilateral)
0.8 to 1.2 Twirling, reinforcing, manipulation <90 >120
Hegu (LI4) Large intestinemeridian Perpendicularly (bilateral) 0.5 to 1 Moderatereinforcing, manipulation 90 to 180 60 to 120
Fenglong (ST40) Stomachmeridian Perpendicularly (bilateral) 1 to 1.5 Twirling, reducing,
twisting, manipulation
>180 <60
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life-threatening condition or progressive central
disorder);
6. Patients who cannot communicate reliably with the
investigator or who are not likely to cope with the
requirements of the trial;
7. Patients receiving or received acupuncture treatment
in past 3 month.
Interventions
Patients who meet the inclusion criteria and none of the
exclusion criteria are randomized to one of two treat-
ment groups. Group A will receive acupuncture in the
Baihui, Yintang, Taiyang, Tinggong, Wangu, Fengchi, Hegu,
Fenglong, and Taichong acupuncture points (Table 1).
Single-use, sterile, 40 mm× 0.25 mm or 25 mm× 0.25 mm
(depending on the area to be treated), silver-handled
needles (HanYi disposable acupuncture needle, made in
Tianjin HuaHong Medical Co., Ltd., Tianjin, China) with-
out guide tubes are used. Needles are correctly inserted
and manually stimulated until the ‘De Qi’ sensation is elic-
ited. The needles will stay in place for 30 min and will be
manually stimulated every 10 min. Only needle acupunc-
ture will be allowed: other forms of acupuncture treatment
(for example, laser acupuncture, electro-acupuncture, or
moxibustion) will not be permitted.
Group B will receive sham acupuncture (shallow nee-
dle insertion that does not penetrate below the skin) at
non-acupoints. The locations of non-acupoints have been
defined in the previous literature [13]. The same type of
needle will be used as group A, but the insertion is super-
ficial and physicians are not instructed to achieve ‘De Qi’.
Treatment will be conducted over a period of 4 weeks,
at a frequency of two sessions per week. No additional
treatment will be allowed.
Education of acupuncturists
Acupuncturists will have an acupuncture license from
the Chinese medicine practitioner license from the
Ministry of Health of the People’s Republic of China and
take an educational course to ensure their strict adher-
ence to the study protocol and familiarity with the
administering study.
Randomization and blinding
A research coordinator will screen and enroll partici-
pants at the clinic. After participants have completed a
baseline evaluation, another research coordinator who is
uninvolved with data collection randomly assigns them
to one of two treatment groups by using a computer-
generated, blocked random-allocation sequence. The ran-
dom list is generated with SAS software (SAS Institute,
Inc., Cary, NC, USA). This research coordinator informs
the acupuncturist of the treatment assignment. Theallocation of the randomization sequence will be con-
cealed centrally by telephone.
The patients, data collection staff, and data analysts
are blinded during the study period. The acupuncturist
is not blinded to the treatment to be delivered because
acupuncture manipulation makes this impossible. During
the intervention, the acupuncturist and the personnel who
collect data will be segregated immediately after the treat-
ment has started and will be instructed not to exchange
information with each other.
Primary outcome measures
Dizziness Handicap Inventory
The Dizziness Handicap Inventory (DHI) is a validated,
self-reported questionnaire, which is widely used to eva-
luate the functional, emotional, and physical impact of
dizziness on patients’ daily life. It consists of 25 questions
about daily problems associated with dizziness, and each
question is given a score of 0, 2, or 4. A score of 0 means
that the condition described in the question never happens,
2 means it sometimes happens, and 4 means it always
happens. Followinga study by Whitney et al. [14], the DHI
scores are graded as mild (0 to 30 points), moderate (31 to
60 points), and severe (61 to 100 points) [15,16].
Vertigo Symptom Scale, Short Form
The Vertigo Symptom Scale (VSS) is used as a measure
of dizziness symptoms. The VSS assesses how frequently
participants have experienced 15 various forms of dizzi-
ness during the previous month. It is rated on a scale
ranging from 0 to 4 and has a maximum score of 60.
Higher scores indicate more vertigo symptoms [17,18].
The DHI and VSS are assessed at baseline (before treat-
ment initiation), 4 weeks after the first acupuncture
session, and 8 weeks after the first acupuncture session.
Secondary outcome measures
Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HAD) inde-
pendently assesses nonsomatic symptoms of anxietyand
depression. Composite scores range between 0 and 21.
Scores between 8 and 10 are borderline values and those
above 10 indicate clinical depression or anxiety [4].
Short Form-36 Quality-of-Life Questionnaire
The Short Form-36 Quality-of-Life Questionnaire (SF-
36) is a widely used tool for evaluating a person’s health
perception in daily life. It consists of 36 questions, which
are grouped into eight health categories as follows: (1)
limitations in physical function because of health prob-
lems; (2) limitations in social function because of phys-
ical or emotional problems; (3) limitations in usual role
activities because of physical health problems; (4) bodily
pain; (5) general mental health (psychological distress
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cause of emotional problems; (7) vitality (energy and fa-
tigue); and (8) general health perceptions [15].Treatment Credibility Scale
Perceived credibility of acupuncture will be evaluated by
the Treatment Credibility Scale after a 4-week acupunc-
ture session. This is a five-item questionnaire ranging
from 1 (not at all) to 5 (very confident): items are aver-
aged to provide a single treatment credibility score, with
high scores reflecting high treatment credibility [13].
To evaluate the adequacy of blinding, we will ask partic-
ipants to rate how certain they are that they have received
traditional acupuncture or the new method of acupunc-
ture on a seven-point scale (1 very sure, 7 very uncertain)
after 4 weeks of treatment [13].
The HAD and SF-36 will be assessed at baseline (be-
fore treatment initiation), 4 weeks after the first acu-
puncture, and 8 weeks after the first acupuncture. The
Treatment Credibility Scale and the adequacy of blind-
ing will only be evaluated after the acupuncture session
on the fourth week.Safety
Participants should report any adverse events they experi-
ence, including discomfort or bruising at the sites of nee-
dle insertion, nausea, or feeling faint after each treatment.Sample size
We have performed sample size calculations for chronic
dizziness according to other studies on the same disease
using the same primary outcome measure because no
such acupuncture research has been reported [19-21]. The
estimated sample size was calculated considering previous
DHI results. Calculations are performed using 80% power
and a (two-sided) 5% significance level. Estimations indi-
cated 263 individuals for the DHI assessments (effect size =
0.41; standard deviation = 0.7), where effect size is the mean
difference expected between the two groups and standard
deviation is for the population. We plan to enroll a total of
100 participants with 50 in each group, allowing for a 15%
withdrawal rate.Data analysis
Descriptive statistics will be used to describe demo-
graphic and baseline characteristics of study participants.
Repeated measuresanalysis of variance will be used to
test the between-group differences. The accepted level of
significance for all analyses will be P < 0.05. Data analysis
will be conducted by statisticians who are independent
of the research team. Analysis will be conducted using
SPSS software (SPSS 12.0 KO for Windows ©).Discussion
Our study is, to date, the first randomized controlled
clinical trial on the efficacy of acupuncture in patients
with chronic dizziness.
The word dizziness is used to mean various sensations
of body orientation and position that are frequently diffi-
cult for patients to describe. Dizziness is difficult to de-
fine, impossible to measure, and a challenge to diagnose
[22]. Most patients with chronic symptoms are not re-
lieved by medical treatment [23]. Chronic dizziness is a
major public health concern. There are millions of pa-
tients with chronic dizziness. However, neither the mech-
anism nor safe and effective treatment methods have been
clarified. Any treatment method that reduces chronic diz-
ziness would be an important intervention. Our study will
indicate that, despite the difficulty of diagnosis, practi-
tioners can identify patients who can safely benefit from
acupuncture. A number of patients with dizziness would
prefer acupuncture over pharmacotherapy when our study
demonstrates the effectiveness and safety of acupuncture
to treat chronic dizziness. This will be especially relevant
for patients who do not respond to medical therapy or
who experience adverse side effects to drug therapy.
In our study, the acceptability of acupuncture will be
reported by patients. Our findings provide insight into a
key factor related to effectiveness, namely acceptability
of treatment. Acceptability is an important factor because it
will impact on the take-up of the treatment offered and the
compliance or willingness to see the course of treatment
through [24]. We will report on patients’ experiences of ac-
ceptability, whether the outcomes from acupuncture are
beneficial or not.
However, our study has several limitations. One limita-
tion concerns the fact that we will recruit patients with
various types of chronic dizziness, although all the pa-
tients referred to acupuncture department will be eligible
for the study. However, effectiveness of acupuncture for
different types of chronic dizziness is not evaluated. An-
other limitation is that the therapist is not blinded in the
present trial. A blinded study of acupuncture would be
challenging to conduct because it is almost impossible to
blind acupuncturists to the treatments they are delivering.
Therefore, a bias due to unblinding cannot be ruled out.
The results of this study will provide a new evidence-
based treatment option for patients suffering chronic
dizziness.Trial status
The trial is currently in the recruitment phase.Abbreviations
DHI: Dizziness handicap inventory; HAD: Hospital anxiety and depression scale;
SF-36: Short form-36 quality-of-life questionnaire; VSS: Vertigo symptom scale.
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